Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
INTEG-B.STthis companyIntegrum AB (publ)	SEK 8.04	-3.96×	1.07×	2.01×	-4.23×	-809.2%	69.2%	-56.4%	-50.7%	-26.9%	-25.4%	-31.6%	0.02×	0.4×	-83.91×	2.77×	0.0%	1	4.67	2	C+
ALZ.STAlzinova AB (publ)	SEK 0.33	-3.19×	0.68×	0×	-3.24×	-103.5%	0.0%	0.0%	0.0%	-21.5%	-20.9%	-47.5%	0.01×	-0.02×	-27.71×	0.11×	0.0%	3	5.43	2	C+
ANNX.STAnnexin Pharmaceuticals AB	SEK 9.44	-3.55×	5.25×	0×	-2.81×	-42.7%	0.0%	0.0%	0.0%	-148.0%	-145.6%	-28.3%	0×	0.74×	0×	5.47×	0.0%	1	-32.9	1	C-
BRAIN.STBrainCool AB (publ)	SEK 1.06	-3.95×	0.85×	4.14×	-3.68×	-1142.9%	-112.9%	-95.1%	-102.3%	-21.1%	-18.8%	-37.7%	0×	1.32×	-8.86×	7.03×	0.0%	2	22.35	1	C-
CLS-B.STClinical Laserthermia Systems AB (publ)	SEK 1.74	-4.27×	2.55×	10.18×	-5.92×	-9742.7%	-165.8%	-165.8%	-238.0%	-59.7%	-43.6%	-20.2%	0×	0.82×	-308.57×	3.91×	0.0%	1	-0.88	1	C-
ERMA.STEnorama Pharma AB (publ)	SEK 0.76	-1.77×	-5.66×	48.45×	-2.1×	-104.0%	-2255.6%	-2268.0%	-2743.3%	320.4%	264.9%	-44.7%	0×	0.05×	-4.91×	0.25×	0.0%	2	-29.47	2	C
Peer median	—	-3.55×	0.85×	4.14×	-3.24×	-104.0%	-112.9%	-95.1%	-102.3%	-21.5%	-20.9%	-37.7%	0×	0.74×	-8.86×	3.91×	0.0%	2	-0.88	1	—